My read on this is that patients who have severe disease will still prove difficult to treat as the increased gene expression from PYCs drug won't make up for the inheritant deficit in those patients. At this stage, based on the deck, it looks good if you have mild or lightly moderate disease.
- Forums
- ASX - By Stock
- PYC
- Ann: Polycystic Kidney Disease Program Investor Presentation
PYC
pyc therapeutics limited
Add to My Watchlist
4.23%
!
$1.25

Ann: Polycystic Kidney Disease Program Investor Presentation, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.25 |
Change
-0.055(4.23%) |
Mkt cap ! $726.1M |
Open | High | Low | Value | Volume |
$1.26 | $1.26 | $1.24 | $173.1K | 139.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 33352 | $1.24 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.30 | 7691 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 33352 | 1.240 |
2 | 1833 | 1.200 |
1 | 10000 | 1.190 |
3 | 10888 | 1.180 |
1 | 1702 | 1.175 |
Price($) | Vol. | No. |
---|---|---|
1.300 | 7691 | 1 |
1.310 | 7427 | 1 |
1.320 | 10000 | 1 |
1.335 | 475 | 1 |
1.340 | 9300 | 1 |
Last trade - 16.10pm 07/08/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |